Iveric Bio

$14.12 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About Iveric Bio

IVERIC bio, Inc. operates as a biopharmaceutical company. The Company develops treatments for patients with orphan inherited retinal diseases with significant unmet medical needs. IVERIC bio serves customers in the United States.

Stock Analysis

last close $14.12
1-mo return -20.7%
3-mo return 35.1%
avg daily vol. 1.25M
52-week high 19.32
52-week low 4.96
market cap. $1.8B
forward pe -
annual div. -
roe -48.5%
ltg forecast -
dividend yield -
annual rev. $--
inst own. 96.8%

Subscribe now for daily local and international financial news